SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-08 17:27
Tx date 2024-03-04
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$16,666
+16,666 vol
$1.00 each
247,485
Filed 2024-03-08 17:21
Tx date 2024-03-04
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-16,666
-16,666 vol
$1.00 each
20,000
Filed 2024-03-06 11:38
Tx date 2024-03-06
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,600
+24,000 vol
$0.40 each
254,819
Filed 2024-01-13 15:48
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$12,482
+11,666 vol
$1.07 each
202,819
Filed 2024-01-13 15:47
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-12,482.62
-11,666 vol
$1.07 each
71,666
Filed 2023-11-18 15:28
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$5,200
+5,000 vol
$1.04 each
191,153
Filed 2023-11-18 15:27
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-5,200
-5,000 vol
$1.04 each
83,332
Filed 2023-09-15 17:49
Tx date 2023-09-12
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+108,000 vol
144,000
Filed 2023-05-03 13:23
Tx date 2023-05-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$8,999
+16,666 vol
$0.54 each
186,153
Filed 2023-05-03 13:22
Tx date 2023-05-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-8,999.64
-16,666 vol
$0.54 each
88,332
Filed 2023-03-06 12:18
Tx date 2023-03-03
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$8,500
+16,667 vol
$0.51 each
169,487
Filed 2023-03-06 12:17
Tx date 2023-03-03
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-8,500.17
-16,667 vol
$0.51 each
104,998
Filed 2023-01-14 15:44
Tx date 2023-01-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$6,883
+11,667 vol
$0.59 each
152,820
Filed 2023-01-14 15:44
Tx date 2023-01-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-6,883.53
-11,667 vol
$0.59 each
121,665
Filed 2022-11-19 12:05
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$2,400
+5,000 vol
$0.48 each
127,623
Filed 2022-11-19 12:04
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-2,400
-5,000 vol
$0.48 each
133,332
Filed 2022-11-19 12:00
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+36,000 vol
36,000
Filed 2022-11-19 11:58
Tx date 2020-05-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-11-16 20:05
Tx date 2022-11-16
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,897
+13,530 vol
$0.362 each
136,153
Filed 2022-08-19 14:12
Tx date 2022-08-16
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,716
+3,300 vol
$0.52 each
122,623
Filed 2022-08-19 14:11
Tx date 2022-08-16
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,384
+8,120 vol
$0.54 each
119,323
Filed 2022-08-19 14:09
Tx date 2022-08-16
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,335
+8,500 vol
$0.51 each
111,203
Filed 2022-05-05 11:55
Tx date 2022-05-02
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+16,667 vol
102,703
Filed 2022-05-05 11:54
Tx date 2022-05-02
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-16,667 vol
138,332
Filed 2022-03-07 14:33
Tx date 2022-03-03
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+16,667 vol
86,036
Filed 2022-03-07 14:32
Tx date 2022-03-03
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-16,667 vol
154,999
Filed 2022-01-13 13:45
Tx date 2022-01-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+11,667 vol
69,369
Filed 2022-01-13 13:44
Tx date 2022-01-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-11,667 vol
171,666
Filed 2021-11-19 20:42
Tx date 2021-11-15
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+30,000 vol
183,333
Filed 2021-11-01 19:37
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,999
+13,888 vol
$0.72 each
57,702
Filed 2021-10-13 22:22
Tx date 2021-05-03
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+16,667 vol
26,471
Filed 2021-10-13 22:21
Tx date 2021-05-03
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-16,667 vol
153,333
Filed 2021-10-13 22:19
Tx date 2021-03-03
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+50,000 vol
170,000
Filed 2021-08-05 18:10
Tx date 2021-08-05
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,864
+17,343 vol
$0.86 each
27,147
Filed 2021-01-15 18:49
Tx date 2021-01-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+70,000 vol
120,000
Filed 2020-12-17 18:31
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
37 - Stock split or consolidation

-450,000 vol
50,000
Filed 2020-12-17 18:30
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-88,235 vol
9,804
Filed 2020-09-25 20:05
Tx date 2020-09-24
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$33,333
+98,039 vol
$0.34 each
98,039
Filed 2020-06-15 13:03
Tx date 2020-06-11
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+500,000 vol
500,000
Filed 2020-05-19 21:32
Tx date 2020-05-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-19 21:32
Tx date 2020-05-01
$ATE
Antibe Therapeutics Inc.
Stauffer, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report